Yared Hailemichael

2.6k total citations
29 papers, 1.4k citations indexed

About

Yared Hailemichael is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yared Hailemichael has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 20 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Yared Hailemichael's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (9 papers). Yared Hailemichael is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (9 papers). Yared Hailemichael collaborates with scholars based in United States, Australia and China. Yared Hailemichael's co-authors include Willem W. Overwijk, Kimberly S. Schluns, Yanyan Lou, Chengwen Liu, Weiyi Peng, Andrew G. Sikora, Zhimin Dai, Alexander Gelbard, Brian Rabinovich and Padmini Jayaraman and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Yared Hailemichael

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yared Hailemichael United States 16 1.0k 669 508 150 93 29 1.4k
John Kwon United States 7 842 0.8× 392 0.6× 591 1.2× 172 1.1× 95 1.0× 10 1.3k
Januario E. Castro United States 25 682 0.7× 808 1.2× 1.1k 2.1× 100 0.7× 118 1.3× 124 2.3k
Norma Bloy France 19 841 0.8× 776 1.2× 483 1.0× 117 0.8× 63 0.7× 39 1.5k
Chuanhui Han United States 15 613 0.6× 399 0.6× 463 0.9× 78 0.5× 186 2.0× 29 1.1k
Evangelia Bolli Belgium 15 707 0.7× 420 0.6× 444 0.9× 102 0.7× 143 1.5× 15 1.2k
Alexandra Flemming United States 16 554 0.5× 237 0.4× 526 1.0× 125 0.8× 78 0.8× 177 1.3k
Simone Gaedicke Germany 18 354 0.3× 497 0.7× 362 0.7× 137 0.9× 141 1.5× 27 1.0k
Mirna Balsamo Italy 15 1.3k 1.2× 723 1.1× 294 0.6× 206 1.4× 44 0.5× 17 1.7k
Geoffrey Guittard France 14 540 0.5× 476 0.7× 419 0.8× 94 0.6× 76 0.8× 27 1.1k
Dipti Vijayan Australia 13 640 0.6× 506 0.8× 351 0.7× 101 0.7× 101 1.1× 15 1.2k

Countries citing papers authored by Yared Hailemichael

Since Specialization
Citations

This map shows the geographic impact of Yared Hailemichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yared Hailemichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yared Hailemichael more than expected).

Fields of papers citing papers by Yared Hailemichael

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yared Hailemichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yared Hailemichael. The network helps show where Yared Hailemichael may publish in the future.

Co-authorship network of co-authors of Yared Hailemichael

This figure shows the co-authorship network connecting the top 25 collaborators of Yared Hailemichael. A scholar is included among the top collaborators of Yared Hailemichael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yared Hailemichael. Yared Hailemichael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hailemichael, Yared, et al.. (2022). 914 Regulating negative immune regulators to enhance immune checkpoint blockade antitumor potential. Regular and Young Investigator Award Abstracts. A953–A953. 1 indexed citations
2.
Diab, Adi, Noha Abdel‐Wahab, Daniel H. Johnson, et al.. (2021). 72P Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Annals of Oncology. 32. S1403–S1403. 1 indexed citations
3.
Williams, Leila J., Courtney W. Hudgens, Grant M. Fischer, et al.. (2020). The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies. Molecular Cancer Therapeutics. 20(3). 500–511. 112 indexed citations
4.
Johnson, Daniel H., Yared Hailemichael, Wai Chin Foo, et al.. (2019). Interleukin-6 is potential target to de-couple checkpoint inhibitor-induced colitis from antitumor immunity.. Journal of Clinical Oncology. 37(15_suppl). 2616–2616. 9 indexed citations
5.
Khong, Hiep, Meenu Sharma, Zhimin Dai, et al.. (2018). Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response. The Journal of Immunology. 200(10). 3464–3474. 13 indexed citations
6.
Hailemichael, Yared, Amber N. Woods, Tihui Fu, et al.. (2018). Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. Journal of Clinical Investigation. 128(4). 1338–1354. 62 indexed citations
7.
Ritthipichai, Krit, Cara Haymaker, Xiaohui Yi, et al.. (2017). Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter. Clinical Cancer Research. 23(20). 6151–6164. 54 indexed citations
8.
Tirfessa, Kebede, Crick Lund, Girmay Medhin, et al.. (2017). Food insecurity among people with severe mental disorder in a rural Ethiopian setting: a comparative, population-based study. Epidemiology and Psychiatric Sciences. 28(4). 397–407. 28 indexed citations
9.
Singh, Manisha, Mark J. Cantwell, Zhimin Dai, et al.. (2017). Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nature Communications. 8(1). 1447–1447. 68 indexed citations
10.
Haymaker, Cara, Yi Yang, Junmei Wang, et al.. (2017). Absence of Grail promotes CD8+ T cell anti-tumour activity. Nature Communications. 8(1). 239–239. 25 indexed citations
11.
Haymaker, Cara, Yared Hailemichael, Yi Yang, & Roza Nurieva. (2017). <em>In Vivo</em> Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model. Journal of Visualized Experiments. 4 indexed citations
12.
Anthony, Scott M., et al.. (2015). Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways. PLoS ONE. 10(3). e0120274–e0120274. 27 indexed citations
13.
Hailemichael, Yared & Willem W. Overwijk. (2014). Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination. The International Journal of Biochemistry & Cell Biology. 53. 46–50. 14 indexed citations
14.
Qin, Hong, Ippei Sakamaki, Guo‐Wei Wei, et al.. (2014). Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nature Medicine. 20(6). 676–681. 189 indexed citations
15.
Hailemichael, Yared, Tihui Fu, Hiep Khong, et al.. (2014). Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
16.
Hailemichael, Yared, Zhimin Dai, Yang Ye, et al.. (2013). Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nature Medicine. 19(4). 465–472. 356 indexed citations
17.
Hailemichael, Yared & Willem W. Overwijk. (2013). Peptide-based anticancer vaccines. OncoImmunology. 2(7). e24743–e24743. 18 indexed citations
18.
Lou, Yanyan, Chengwen Liu, Gregory Lizée, et al.. (2011). Antitumor Activity Mediated by CpG. Journal of Immunotherapy. 34(3). 279–288. 56 indexed citations
19.
Sikora, Andrew G., Alexander Gelbard, Michael A. Davies, et al.. (2010). Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy. Clinical Cancer Research. 16(6). 1834–1844. 107 indexed citations
20.
Kong, Ling-Yuan, Alexander Gelbard, Jun Wei, et al.. (2010). Inhibition of p-STAT3 Enhances IFN-α Efficacy against Metastatic Melanoma in a Murine Model. Clinical Cancer Research. 16(9). 2550–2561. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Kwon Breakdown of academic impact, for papers by Januario E. Castro Breakdown of academic impact, for papers by Norma Bloy Breakdown of academic impact, for papers by Chuanhui Han Breakdown of academic impact, for papers by Evangelia Bolli Breakdown of academic impact, for papers by Alexandra Flemming Breakdown of academic impact, for papers by Simone Gaedicke Breakdown of academic impact, for papers by Mirna Balsamo Breakdown of academic impact, for papers by Geoffrey Guittard Breakdown of academic impact, for papers by Dipti Vijayan
Rankless by CCL
2026